Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 617, pseudogene (RN7SL617P) is a member of a large family of human 7SL RNA pseudogenes, which are genomic sequences derived from the reverse transcription and integration of the 7SL RNA gene but do not produce a functional RNA product[1][5][6]. The functional 7SL RNA is a crucial component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum[3][4]. However, the vast majority of RN7SL pseudogenes, including RN7SL617P, are truncated copies and do not have an established biological role or therapeutic relevance; they are considered noncoding and nonfunctional remnants[5][6]. There are no known associated proteins, disease roles, or interactions with drugs for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 617, pseudogene (RN7SL617P).